relapsed/refractory DLBCL
Conditions
Interventions
Group Chinese and Western medicine:XiaoLiu Formula combined with gemcibine-based regimen
Group Western mendicine:gemcibine-based regimen
Sponsors
Shanxi Provincial Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: (1) Age > 18 years, expected survival =3 months; (2) DLBCL patients who meet the western medicine diagnostic criteria and TCM syndrome type diagnostic criteria and have been diagnosed pathologically or cytologically; (3) Willing to accept the treatment; (4) Those who are not suitable for or unwilling to undergo autologous hematopoietic stem cell transplantation; (5) No other primary tumors and serious heart, liver and kidney diseases; (6) Those who have the telephone number and address of follow-up, are willing to cooperate with follow-up, have relatively complete medical records, and have signed informed consent.
Exclusion criteria
Exclusion criteria: (1) Have been diagnosed with malignancies other than non-Hodgkins' lymphoma; (2) Pregnant or lactating women; (3) Unable or unwilling to receive TCM treatment; (4) Dysfunction of heart, liver, kidney and other organs; (5) Hepatitis active stage; (6) There are obvious signs or symptoms of inflammation; (7) Consciousness and mental disorders, lack of independent judgment ability.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of Life;overall survival;Progression-Free Survival;TCM Symptom Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| size of tumor;inflammation state;Card-style functional status score;Tumor burden index; | — |
Countries
China
Contacts
Public ContactZhang Fupeng
Outcome results
None listed